AIChE 2010 Pharma and QbD Program Looks Excellent

The 2010 AIChE Annual Meeting (Salt Lake City, 7-12 November) features 12 oral sessions in the QbD Topical Conference and 12 additional oral sessions on other Pharma topics. There's also a QbD Mixer social event on Tuesday 9 November that includes presentation of two new AIChE Awards for Excellence in QbD.

Highlights include the Tuesday morning session on 'Challenges Facing CMC Organizations in the Changing Business and Regulatory Environment', featuring:

QbD and the Transition From Wyeth to Pfizer for API Small-Molecule Development and Manufacture
John L. Dillon, Pfizer

Advancing the Abbott Pipeline
Howard E. Morton, Abbott Laboratories

Commercialization and Quality by Design: Towards An Improved Model for Pharmaceutical Development, Launch and Supply
Michael P. Thien, Merck & Co., Inc.

Creating a Capabilities Driven Organization: Efficient Design of API Processes
Bret E. Huff, Eli Lilly and Company

You can find the full Pharma program listing here. And you can register for the meeting here.